Utility of Dried Blood Spots for the Diagnosis of Congenital Cytomegaloviruses within the First 21 Days of Life in a Single Center

• Published in: International journal of neonatal screening Vol. 9; no. 3; p. 44
• Main Authors: Del Valle Penella, Ana, Miller, Jerry, Rochat, Ryan, Demmler-Harrison, Gail
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 04-08-2023; MDPI
• Subjects: Asymptomatic; Blood; Cell culture; congenital CMV; Congenital diseases; Cytomegalovirus; Cytomegalovirus infections; diagnosis of congenital CMV; Dried Blood Spot; Hearing loss; Hospitals; Infections; Medical examination; Medical laboratories; Medical records; Medical screening; Newborn babies; newborn screening for congenital CMV; Patients; Plasma; Urine; Virus diseases; United States > US; Texas
• ISSN: 2409-515X; 2409-515X
• DOI: 10.3390/ijns9030044

In this retrospective study, we aimed to evaluate the performance of dried-blood-spot (DBS) testing as a diagnostic method for the congenital cytomegalovirus (cCMV). We reviewed the medical records and DBS test results of 89 patients who had also undergone diagnostic cCMV testing within the first 21 days of life. The DBS test had a sensitivity of 83.9%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 73%. Patients with a true-positive DBS had a higher median level of CMV in blood according to PCR than those with a false-negative result. Additionally, all patients with cCMV and hearing loss had a positive DBS test, with higher median viremia levels observed in those with hearing loss compared to those without a CMV PCR blood test. These results suggest that DBS-based testing is useful in the diagnosis of cCMV, and its performance may be related to levels of CMV viremia. DBS testing accurately identified those patients with congenital/early onset hearing loss and those at risk of developing late-onset hearing loss.